Global Considerations for Special Interest AEs & AESIs Across US, EU and UK Programs
Global Considerations for Special Interest AEs & AESIs Across US, EU and UK Programs The acknowledgment and management of Adverse Events (AEs) and Adverse Events of Special Interest (AESIs) are critical components in the conduct of clinical trials. Given the rise in regulatory scrutiny and the increasing complexity of clinical trial landscapes, professionals engaged in…
Read More “Global Considerations for Special Interest AEs & AESIs Across US, EU and UK Programs” »